---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-084332"
form_type: "8-K"
ticker: "NVCT"
cik: "0001875558"
company_name: "Nuvectis Pharma, Inc."
filed_at: "2022-07-29T23:59:59+00:00"
generated_at: "2026-06-24T07:04:13.593499+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nuvectis Pharma raises ~$15.9M in private placement of common stock and warrants

## Summary
- Gross proceeds $15.9M from sale of 1,924,689 shares or pre-funded warrants at $8.25 per share plus preferred investment options.
- Preferred investment options exercisable at $9.65, lockout 6 months, term 3.5 years.
- H.C. Wainwright acted as placement agent with 7% cash fee plus 115,481 placement agent warrants at $10.3125.
- Net proceeds intended for working capital and general corporate purposes.
- Closing expected July 29, 2022, subject to customary conditions.

## SEC filing metadata
- accession: 0001104659-22-084332
- form_type: 8-K
- ticker: NVCT
- cik: 0001875558
- company_name: Nuvectis Pharma, Inc.
- filed_at: 2022-07-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1875558/000110465922084332/0001104659-22-084332-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1875558/000110465922084332/tm2222131d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-084332
- JSON: https://secwatch.observer/filing/0001104659-22-084332.json
- Plain text: https://secwatch.observer/filing/0001104659-22-084332.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.